Novozymes A/S (OTCMKTS:NVZMY) Sees Large Increase in Short Interest

Novozymes A/S (OTCMKTS:NVZMY) was the target of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 500 shares, an increase of 150.0% from the November 15th total of 200 shares. Based on an average daily trading volume, of 32,300 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Ratings Changes

Several brokerages have commented on NVZMY. Barclays raised Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th. Citigroup downgraded Novozymes A/S from a “neutral” rating to a “sell” rating in a research report on Thursday, October 17th. Finally, Berenberg Bank raised Novozymes A/S to a “strong-buy” rating in a research report on Tuesday, September 24th.

Novozymes A/S Trading Down 0.4 %

Novozymes A/S stock traded down $0.23 during mid-day trading on Friday, hitting $58.66. The stock had a trading volume of 19,720 shares, compared to its average volume of 12,918. The stock has a 50-day simple moving average of $61.63 and a two-hundred day simple moving average of $63.45. The stock has a market capitalization of $27.47 billion, a PE ratio of 37.12, a P/E/G ratio of 3.87 and a beta of 0.87. Novozymes A/S has a 12 month low of $49.99 and a 12 month high of $72.50.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.